護目康ez2視力訓練與兒童近視控制 護目康眼肌協調器榮獲2008台北國際發明奨,並通過碩士論文檢定, 越來越發現每位做父母的遇到小孩子視力的問題總是非常苦惱 這裡提供一個平台互相討論有觀視力保健的問題 內文如有錯誤引用請告知謝謝

52愛的鼓勵 0訂閱站台

FDA發布的消息,將擴大追蹤近視雷射的全面問題, 因為在美國術後造成的問題日益嚴重,

The U.S. Food and Drug Administration has announced the launch of a study to assess the problems faced by patients after LASIK surgery.

The Laser-Assisted In Situ Keratomileusis (LASIK) is a surgical procedure that uses an eximer laser to permanently change the shape of the cornea, but there have been complaints of pain and discomfort from a number of patients. And hence the study� called the LASIK Quality of Life Collaboration Project, in which the FDA will be working with the National Eye Institute and the U.S. Department of Defense. 

Funded by the government agencies, the project is composed of three phases. The objective of Phase 1, which began in July 2009, is to design and implement a Web‑based questionnaire to assess patient-reported outcomes and evaluate quality of life issues post-LASIK, some of which may relate to the safety of the lasers used in the LASIK procedure. 

Phase 2 will evaluate the quality of life and satisfaction following LASIK as reported by patients in a select, active duty population treated at the Navy Refractive Surgery Center. 

Phase 3 will be a national, multi-center clinical trial and will study the impact of the procedure on quality of life following LASIK in the general population. Patient enrollment in Phases 2 and 3 have yet to begin but plans are underway. Phase 3 is expected to end in 2012. 

The results of the project will help identify factors that can affect quality of life following LASIK and potentially reduce the risk of adverse effects that can impact the surgical outcome. If any of these factors are related to the safety or effectiveness of the lasers used in LASIK surgery, the FDA will evaluate whether any action is necessary. The project is part of the FDA ongoing effort to better monitor and improve the safety and effectiveness of the lasers used in LASIK surgery.

文章定位：

台長： 阿諾